We recently previously discovered that TRAIL-R2, but not TRAIL-R1, is capable of mediating cancer progression, invasion, and metastasis by cancer cell-autonomous activation of MPD- Ras-related C3 botulinum toxin substrate 1 (Rac1) axis [39]. This evidence concerns the gene RAC1 and cancer.